A glycoform of serum mucin 1 (MUC1), detected by a combination of monoclonal antibody (mAb) DF3 and mAb 115D8, has long been clinically used as CA15-3 to estimate the tumor burden of breast cancer3. The gene discussed is MUC1; the disease is neoplasm.